Background and Purpose—Statins reduce the risk of stroke in at-risk populations and may
improve outcomes in patients taking statins before an ischemic stroke (IS). Our objectives …

Abstract Background Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors)
have neuroprotective effects in experimental stroke models and are commonly prescribed in …

Background Statins reportedly improve clinical outcomes for ischemic stroke patients.
However, it is unclear whether the contribution of statin treatment varies depending on the …

Background and Purpose—Statins reduce infarct size in animal models of stroke and have
been hypothesized to improve clinical outcomes after ischemic stroke. We examined the …

Background and Purpose—Knowledge of the use of secondary preventive medication in
young adults is limited. We studied the use of statins and its association with subsequent …

Background—In patients with ischemic stroke, data on the real-world effectiveness of statin
therapy for clinical and patient-centered outcomes are needed to better inform shared …

Background and Purpose—In primary and secondary prevention trials, statins have been
shown to reduce the risk of stroke. In addition to lipid lowering, statins have a number of …

Although statin therapy has been shown to be effective in the prevention of ischemic stroke,
its effect on stroke severity and early outcome is still controversial. We aimed to evaluate the …

Background Statin therapy has demonstrated benefits in ischemic stroke patients. However,
little is known about whether the timing of statin initiation affects clinical outcomes. The …

Background and Purpose—Multiple studies suggest that statin use before acute ischemic
stroke is associated with improved functional outcome. However, available evidence is …